ERNs, Publications
Unlocking the potential for rare disease therapies through wider collaborations between European Reference Networks and industry
July 2022
Prominent MEPs seeking quicker wins for rare disease patients are backing closer collaboration between ERNs and pharma companies through a novel multistakeholder initiative.